drugset / Trial / NCT04493255
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
NaSingle-groupOpen-labelOther
Summary
The primary objective of this study is to determine the pharmacokinetics (PK) and excretion of E7090 and its metabolites in healthy male participants. Also, to assess the safety and tolerability of a single dose of E7090 in healthy male participants.
Timeline
- Start
- 2020-09-09
- Primary completion
- 2020-10-21
- Completion
- 2020-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E7090 | Small molecule | 35 mg | Oral |
Indications
No indication recorded.